The Fund aims to provide long term total returns primarily through investment in the shares of companies around the world. Investments will largely be determined by the application of a contrarian investment process and will be in a selection of companies which will not be restricted either by size, industry, or geographical location.
Name | % Net Assets |
---|---|
Pfizer Inc. | 2.4% |
Medtronic Inc. | 2.4% |
Lagardere Groupe | 2.3% |
SK Telecom Co. | 2.2% |
Glaxosmithkline | 2.1% |
NTT Docomo Inc. | 2.1% |
Yamaha Corp | 2.1% |
Helical Bar Plc | 1.9% |
ENI S.P.A. | 1.9% |
Merck & Co Inc. | 1.8% |
Key | % Net Assets |
---|---|
Pfizer Inc. | 2.4% |
Medtronic Inc. | 2.4% |
Lagardere Groupe | 2.3% |
SK Telecom Co. | 2.2% |
Other | 90.7% |
Date | 20-Feb-2023 |
---|---|
NAV | 420.99p |
Currency | GBP |
Change | -4.54p |
% | -1.07% |
YTD change | 420.99p |
YTD % | n/a |
Fund Inception | 17/12/2007 |
---|---|
Fund Manager | n/a |
TER | - |
Minimum Investment | |
---|---|
Initial | £100000000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | n/a |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research